Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05744973 · ClinicalTrials.gov registry record
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
A clinical trial of Racially/Ethnically Diverse Families From Urban Settings, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 631
- Enrollment target
- 2
- Study locations
NCT05744973: Recruiting study of Racially/Ethnically Diverse Families From Urban Settings, sponsored by University of Colorado, Denver.
NCT05744973 is a study of Racially/Ethnically Diverse Families From Urban Settings that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 631 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05744973, a study of Racially/Ethnically Diverse Families From Urban Settings, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 631 participants
- Enrollment target
- 2
- Study locations
Study Summary
Minoritized populations face mutually reinforcing levels of structural disadvantage that contribute to poor health. Despite recognition that social and economic stratification, environmental conditions, and policy are critical determinants of health disparities, there has been limited effort in expanding interventions beyond the individual level to disrupt systemic causes of health. This is in part due to the challenges of describing how racism and discrimination have become systematized over time and across place.68 Studies that do examine SRD and health and well-being, focus on one level of SRD at a time, rather than examining multiple levels simultaneously. Also, the measurement of SRD at all levels has not been very detailed and more research is needed on the nuances of these experiences (e.g., frequency, timeframe, intensity). Finally, there is a need for more prospective longitudinal studies, as most research to date has been cross-sectional. In addition to comprehensively examining the four SRD levels, the current study will examine these multi- level predictors of SRD simultaneously, longitudinally, and across two sites to identify targets for multi-level interventions that will be more likely to be effective and sustainable.
Primary Outcome
comprised of 5 cardiometabolic indicators of lower health - overweight status, triglyceride to HDL ratio, c-reactive protein , stage 1 or 2 hypertension, and elevated HbA1c \>= 5.7across two time points 18 months apart collected in children and adults
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (2)
Georgia
- University of Georgia - Athens
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 631 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2028-01-31 |
What NCT05744973 shows while recruiting
NCT05744973 is an observational study that tracks outcomes without assigning an intervention. The registered 631 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Racially/Ethnically Diverse Families From Urban Settings appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05744973 reports a single indexed study location in Georgia, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05744973 about?
NCT05744973 is a clinical study titled "Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families". Minoritized populations face mutually reinforcing levels of structural disadvantage that contribute to poor health. Despite recognition that social and economic stratification, environmental conditions, and policy are critical determinants of health disparities, there has been limited effort in expa...
What is the current status of trial NCT05744973?
This trial is currently recruiting. The enrollment target is 631 participants. The study started on 2022-11-10. Estimated completion is 2028-01-31.
What conditions does trial NCT05744973 study?
This clinical trial studies the following conditions: Racially/Ethnically Diverse Families From Urban Settings.
What interventions are being tested in trial NCT05744973?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05744973?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05744973 being conducted?
This trial has 2 study locations across Georgia, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI